National Bacterial Meningitis Study in Children and Newborns

Recruiting Observational Study
Meningitis Children, Only Pneumococcal Conjugate Vaccine Meningococcal Vaccines H. Influenzae Vaccine Neonatal Infection Antibiotic Treatment Case Fatality Rate
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
1 Day – 18
Sex
Any
Study type
Observational
Participants needed
10,000 (estimated)
Sponsor
Association Clinique Thérapeutique Infantile du val de Marne · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Bacterial meningitis is a major cause of morbidity and mortality in childhood. Antibiotic treatment recommendations are based on epidemiological and susceptibility data. The epidemiology of bacterialméningitis has changed in recent years, mainly owing to widespread use of different conjugate vaccines. The aim of this prospective national survey is to describe epidemiology of bacteria implicated in…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * clinical signs of meningitis, associated with positive cerebrospinal fluid (CSF) culture and/or positive CSF antigen testing (Escherichia coli K1, N. meningitidis serogroups B, A, C, Y and W-135, group B streptococci, Hib, or S. pneumoniae), and/or positive CSF polymerase chai…
Contacts

Corinne Levy, MD

0033148850404

corinne.levy@activ-france.fr

CONTACT

Stephane Bechet

1 48 85 96 68

stephane.bechet@activ-france.fr

CONTACT